$CTEV

Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks - Claritev (NYSE:CTEV)

HOLLYWOOD, Fla., May 06, 2025 ( GLOBE NEWSWIRE ) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan CTEV, a technology and data insights company focused on making healthcare more affordable, transparent ...

Original reporting
Benzinga · Globe Newswire
Published May 6, 2025, 2:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 7, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks - Claritev (NYSE:CTEV) — source image
Decision brief

The 30-second read

$CTEVBullishMed
01

Why it matters

This partnership is expected to enhance CTEV's revenue streams and market positioning in telehealth services.

02

Market read

The news is highly relevant for investors interested in healthcare technology and telehealth sectors, with immediate trading implications for CTEV.

03

What to watch

Regulatory hurdles or market saturation could limit growth potential.

Timing: Immediate, as the news is recent and relevant for trading today.

Background

Great Speech is expanding its virtual speech therapy services through a new partnership with Claritev, a healthcare data and technology company.

Company-level read

Ticker impact

$CTEVBullishHigh confidence
Context

High relevance due to direct involvement in healthcare services and positive sentiment.

Expected impact

Moderate upward movement expected in the short to medium term.

Evidence & confidence

The news highlights a strategic partnership that expands service offerings, likely leading to increased customer base and revenue, supported by the bullish sentiment and relevance to CTEV.

Market effects

Positive impact on healthcare technology and telehealth sectors.

Potentially favorable in regions where Claritev's network is prominent.

Moderate, as the partnership may influence global telehealth trends.

Counterpoint

The positive news may already be priced in; any delays in implementation or integration issues could negate gains.

Key entities

  • Great Speech

    A leader in virtual speech therapy services.

  • Claritev

    A healthcare data and technology firm focusing on affordability and transparency.

Related articles

$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

$CTEVMed

Claritev Corp (CTEV): Results of Operations and Financial Condition

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202

$WMTMed

Walmart Rolls Back Prices Thanks to a $2.9 Billion Tariff Refund — Here Are the Best Deals

Walmart is using a $2.9 billion tariff refund to lower prices on 11,000 items, including groceries and general merchandise, across its retail stores, Sam's Club, and digital platforms. The company views this as a long-term investment in customer loyalty, even if it pressures short-term profits. Walmart's CFO, John David Rainey, announced this during the latest earnings call, according to CBS News.

$MTDHigh

Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth

Redburn initiated coverage of Mettler-Toledo (MTD) with a Sell rating and a $1,200 price target, citing a premium valuation and modest growth outlook. The brokerage expects revenue to reach $4.25B in 2026 and $4.44B in 2027, with adjusted EPS of $47.29 and $51.40, respectively. Redburn highlights competition and pressure in China as concerns, despite the company's strong returns and market position.

$AIGMed

Zaffino to leave AIG, join Palantir

Peter Zaffino will leave AIG as executive chairman on Sept. 15 to join Palantir as global head of financial services in January. John Rice, AIG's lead independent director, will succeed Zaffino as chairman. Zaffino led AIG's turnaround efforts since 2017. AIG and Palantir announced the changes.